Serotonin (5-HT) receptor 5A sequence variants affect human plasma triglyceride levels
MetadataShow full item record
Neurotransmitters such as serotonin (5-hydroxytryptamine, 5-HT) work closely with leptin and insulin to fine-tune the metabolic and neuroendocrine responses to dietary intake. Losing the sensitivity to excess food intake can lead to obesity, diabetes, and a multitude of behavioral disorders. It is largely unclear how different serotonin receptor subtypes respond to and integrate metabolic signals and which genetic variations in these receptor genes lead to individual differences in susceptibility to metabolic disorders. In an obese cohort of families of Northern European descent (n = 2,209), the serotonin type 5A receptor gene, HTR5A, was identified as a prominent factor affecting plasma levels of triglycerides (TG), supported by our data from both genome-wide linkage and targeted association analyses using 28 publicly available and 12 newly discovered single nucleotide polymorphisms (SNPs), of which 3 were strongly associated with plasma TG levels (P < 0.00125). Bayesian quantitative trait nucleotide (BQTN) analysis identified a putative causal promoter SNP (rs3734967) with substantial posterior probability (P = 0.59). Functional analysis of rs3734967 by electrophoretic mobility shift assay (EMSA) showed distinct binding patterns of the two alleles of this SNP with nuclear proteins from glioma cell lines. In conclusion, sequence variants in HTR5A are strongly associated with high plasma levels of TG in a Northern European population, suggesting a novel role of the serotonin receptor system in humans. This suggests a potential brain-specific regulation of plasma TG levels, possibly by alteration of the expression of HTR5A. Copyright © 2010 the American Physiological Society.
Showing items related by title, author, creator and subject.
Bozaoglu, K.; Attard, C.; Kulkarni, H.; Cummings, N.; Diego, V.; Carless, M.; Shields, K.; Johnson, M.; Kowlessur, S.; Dyer, T.; Comuzzie, A.; Almasy, L.; Zimmet, P.; Moses, Eric; Göring, H.; Curran, J.; Blangero, J.; Jowett, J. (2014)Context: Adipokines actuate chronic, low-grade inflammation through a complex network of immune markers, but the current understanding of these networks is incomplete. The soluble isoform of the IL-1 receptor accessory ...
IDOL N342S variant, atherosclerosis progression and cardiovascular disorders in the italian general populationDhyani, A.; Tibolla, G.; Baragetti, A.; Garlaschelli, K.; Pellegatta, F.; Grigore, L.; Norata, Giuseppe; Catapano, A. (2015)Inducible degrader of the low density lipoprotein receptor (IDOL), is an E3 ubiquitin ligase that negatively modulates low density lipoprotein receptor (LDL-R) expression. Genome-wide association studies (GWAS) indicated ...
Differential regulation of sphingolipid metabolism in plasma, hippocampus and cerebral cortex of mice administered sphingolipid modulating agentsGiles, Corey; Takechi, Ryu; Mellett, N.; Meikle, P.; Dhaliwal, Satvinder; Mamo, John (2017)Accumulation of ceramide is implicated in mediating the cellular responses to stress and aberrant sphingolipid metabolism is frequently associated with metabolic and neurodegenerative diseases. It is often assumed that ...